-
Mashup Score: 4ASH24Highlights of ASH in Latin America - 5 day(s) ago
Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology. April 25-26, 2025 Punta del Este Convention & Exhibition Center | Punta del Este, Uruguay Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2ASH24Highlights of ASH in Latin America - 5 day(s) ago
Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology. April 25-26, 2025 Punta del Este Convention & Exhibition Center | Punta del Este, Uruguay Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
๐ข O 2025 Highlights of ASHยฎ in Latin America estรก chegando! ๐ 25-26 abril | ๐ Punta del Este, Uruguai ๐ฌ Atualize-se com o melhor da ASH Annual Meeting #ASH24: Especialistas globais; Lunch with the Experts e Sunset Session ๐ Inscreva-se agora! ๐ https://t.co/yeqbeN2tEa https://t.co/fqW3fA8Kqs
-
-
Mashup Score: 0ASH24Key Lymphoma Abstracts from ASH 2024 - 5 day(s) ago
Join us live as Dr Alex Herrera and Dr Matthew Lunning discuss key lymphoma data presented at the annual hematology meeting in San Diego! Drs Herrera and Lun…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
๐ ๐๐๐๐๐ at #ASH24! Review the latest clinical data and trial evidence across lymphoma types and better understand the impacts on clinical disease management at this expert LIVE discussion! WATCH ON MARCH 18! โก๏ธ https://t.co/e7npH0Az0z https://t.co/co1xnzDCkB
-
-
Mashup Score: 0ASH24Key Lymphoma Abstracts from ASH 2024 - 6 day(s) ago
Join us live as Dr Alex Herrera and Dr Matthew Lunning discuss key lymphoma data presented at the annual hematology meeting in San Diego! Drs Herrera and Lun…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
๐ ๐๐๐๐๐ at #ASH24! Review the latest clinical data and trial evidence across lymphoma types and better understand the impacts on clinical disease management at this expert LIVE discussion! WATCH ON MARCH 18! โก๏ธ https://t.co/e7npH0Az0z https://t.co/co1xnzDCkB
-
-
Mashup Score: 222KidneyWk
In the EMPA-KIDNEY trial, empagliflozin, a sodiumโglucose cotransporter 2 (SGLT2) inhibitor, had positive cardiorenal effects in patients with chronic kidney disease who were at risk for disease pr…
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet-
Presented at #KidneyWk: Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: https://t.co/yVvVg7V37b https://t.co/970lxOslk0
-
๐ข ยกEl 2025 Highlights of ASHยฎ in Latin America se acerca! ๐ 25-26 abril | ๐ Punta del Este, Uruguay ๐ฌ Actualรญzate con lo mejor de la ASH Annual Meeting #ASH24: Especialistas globales, Lunch with the Experts y Sunset Session. ๐ ยกInscrรญbete ahora! ๐ https://t.co/jC67wvLLJm https://t.co/sOMq03l3xo